Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice-Reference-Cited by-同舟云学术

Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice

Published:2023-11 Issue: Volume:167 Page:115489
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lin Qianyun,Li Zitong^ORCID,Lu Lei,Xu Hua,Lou Eddie,Chen Alyssa,Sun Dustin,Zhang Wuyi,Zhu Weishu,Yee Eric U.,Sears Pamela Suzanne,Chen Xinhua,Kelly Ciaran P.

Funder

National Institute of Allergy and Infectious Diseases

Merck

National Institutes of Health

Optimer Pharmaceuticals

National Natural Science Foundation of China

Beijing Friendship Hospital, Capital Medical University

Foundation for the National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Global trends in gut microbiota and clostridioides difficile infection research: a visualized study;Li;J. Infect. Public Health,2022

2. The emerging metabolic view of Clostridium difficile pathogenesis;Hryckowian;Curr. Opin. Microbiol.,2017

3. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults;van Prehn;Clin. Microbiol. Infect.,2021

4. Epidemiology of community-acquired and recurrent Clostridioides difficile infection;Fu;Ther. Adv. Gastroenterol.,2021

5. Current treatment options for severe clostridium difficile-associated disease;Shen;Gastroenterol. Hepatol.,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Fecal microbiota transplantation in clinical practice: Present controversies and future prospects;hLife;2024-06